Abstract
Forests face increasing threats due to climate change and anthropogenic pressures, exacerbating plant stress and disease susceptibility. Norway spruce (Picea abies (L.) H. Karst.), a key conifer species in European forestry, is particularly vulnerable. Developing innovative seed treatments to enhance tree resilience is crucial for sustainable forest management. Despite the growing interest in cold plasma (CP) technology for seed treatment, research on its long-term effects on trees, particularly Norway spruce, remains scarce. This study aimed to investigate the effects of pre-sowing CP treatment on Norway spruce seeds from 10 half-sib families over two vegetation seasons. Results indicate that CP treatment influenced key physiological and biochemical parameters in a genotype-specific and treatment duration-dependent manner (1 or 2 min). In some cases, CP-treated seedlings exhibited increased chlorophyll levels (e.g., increased chlorophyll a by up to 49% in some genotypes treated with CP for 1 min, and by up to 35% in those treated with CP for 2 min), reduced malondialdehyde (MDA) content in second-year samples (by up to 52% in some genotypes), and enhanced production of phenolics (by up to 21% in some genotypes in both treatment groups), suggesting improved stress tolerance. The 541 half-sib family is particularly noteworthy, as first-year seedlings exhibited increased levels of chlorophylls, flavonoids, and total phenols following a 2 min treatment. In contrast, second-year seedlings of the same family showed an increase in flavonoids and a reduction in MDA levels compared to the control, indicating a sustained and possibly age-modulated physiological response to CP exposure (2 min). However, responses varied across genetic backgrounds, highlighting the importance of genotype in determining treatment efficacy. These findings underscore the potential of CP technology as a tool for improving Norway spruce resilience and inform future strategies for seed enhancement in forestry.